Drug intelligence / Profile preview

Gynergi

Development stage: Unknown
Lead developer: Rantomo Lifesciences
Administration: Oral

Overview

**Gynergi** is a marketed oral nutraceutical product from Rantomo Life Sciences Bharat. The manufacturer describes it as a vitality-support supplement containing docosahexaenoic acid and folic acid, with stated support for red blood cell health and prevention of anemia and birth defects. The available public product information does not disclose ingredient strengths, the complete formulation, dosage form, or a specific molecular mechanism of action. ([rantomo.com](https://www.rantomo.com/gynergi))

Brand names: Gynergi

Beyond the preview

Go deeper on Gynergi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gynergi.

Explore the full profile